ClinicalTrials.govpublic full text
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
cervical cancer, uterine cancer, bevacizumab, avastin, anti-vegf monoclonal antibody, rhumab-vegf, paclitaxel, taxol, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 872835
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.